INNO-GENE SA ZY -10 (WQ3) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.003x

Based on the latest financial reports, INNO-GENE SA ZY -10 (WQ3) has a cash flow conversion efficiency ratio of 0.003x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€54.00K ≈ $63.13K USD) by net assets (€17.55 Million ≈ $20.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

INNO-GENE SA ZY -10 - Cash Flow Conversion Efficiency Trend (2021–2024)

This chart illustrates how INNO-GENE SA ZY -10's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read INNO-GENE SA ZY -10 (WQ3) total liabilities for a breakdown of total debt and financial obligations.

INNO-GENE SA ZY -10 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of INNO-GENE SA ZY -10 ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Guardforce AI Co Ltd NASDAQ:GFAI	-0.017x
Batavia Prosperindo Trans Tbk PT JK:BPTR	0.059x
Wise Group AB ST:WISE	0.075x
BALAXI PHARMACEUTICALS LIMITED NSE:BALAXI	0.063x
Intrasoft Technologies Limited NSE:ISFT	0.042x
GigaMedia Limited F:GIFN	N/A
Applied Therapeutics Inc NASDAQ:APLT	32.800x
Mason Capital Corporation KQ:021880	0.043x

Annual Cash Flow Conversion Efficiency for INNO-GENE SA ZY -10 (2021–2024)

The table below shows the annual cash flow conversion efficiency of INNO-GENE SA ZY -10 from 2021 to 2024. For the full company profile with market capitalisation and key ratios, see INNO-GENE SA ZY -10 (WQ3) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€18.02 Million ≈ $21.06 Million	€-1.13 Million ≈ $-1.32 Million	-0.063x	+93.85%
2023-12-31	€2.44 Million ≈ $2.85 Million	€-2.49 Million ≈ $-2.91 Million	-1.020x	-74759.14%
2022-12-31	€8.05 Million ≈ $9.41 Million	€11.00K ≈ $12.86K	0.001x	-99.84%
2021-12-31	€7.85 Million ≈ $9.17 Million	€6.75 Million ≈ $7.89 Million	0.861x	--

About INNO-GENE SA ZY -10

F:WQ3 Germany Specialty Chemicals

Market Cap

$14.88 Million

€12.73 Million EUR

Market Cap Rank

#26048 Global

#2254 in Germany

Share Price

€0.38

Change (1 day)

+0.00%

52-Week Range

€0.34 - €0.41

All Time High

€4.46